These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24935901)

  • 1. Evaluation of neurotransmitter receptor gene expression identifies GABA receptor changes: a follow-up study in antipsychotic-naïve patients with first-episode psychosis.
    Ota VK; Noto C; Gadelha A; Santoro ML; Ortiz BB; Andrade EH; Tasso BC; Spindola LM; Silva PN; Abílio VC; Smith Mde A; Sato JR; Brietzke E; Cordeiro Q; Bressan RA; Belangero SI
    J Psychiatr Res; 2014 Sep; 56():130-6. PubMed ID: 24935901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotransmitter receptor and regulatory gene expression in peripheral blood of Brazilian drug-naïve first-episode psychosis patients before and after antipsychotic treatment.
    Ota VK; Noto C; Gadelha A; Santoro ML; Silva PN; Melaragno MI; Smith Mde A; Cordeiro Q; Bressan RA; Belangero SI
    Psychiatry Res; 2013 Dec; 210(3):1290-2. PubMed ID: 24113126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in gene expression and methylation in the blood of patients with first-episode psychosis.
    Ota VK; Noto C; Gadelha A; Santoro ML; Spindola LM; Gouvea ES; Stilhano RS; Ortiz BB; Silva PN; Sato JR; Han SW; Cordeiro Q; Bressan RA; Belangero SI
    Schizophr Res; 2014 Nov; 159(2-3):358-64. PubMed ID: 25270546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of NDEL1 and MBP genes in the peripheral blood of antipsychotic-naïve patients with first-episode psychosis.
    Ota VK; Noto C; Santoro ML; Spindola LM; Gouvea ES; Carvalho CM; Santos CM; Xavier G; Higuchi CH; Yonamine C; Moretti PN; Abílio VC; Hayashi MA; Brietzke E; Gadelha A; Cordeiro Q; Bressan RA; Belangero SI
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2416-25. PubMed ID: 26476704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis.
    Noto C; Ota VK; Gouvea ES; Rizzo LB; Spindola LM; Honda PH; Cordeiro Q; Belangero SI; Bressan RA; Gadelha A; Maes M; Brietzke E
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risperidone in the early treatment of first-episode psychosis: a two-year follow-up study].
    Gutiérrez Fraile M; Segarra Echevarría R; González-Pinto Arrillaga A; Martínez Junquera G
    Actas Esp Psiquiatr; 2002; 30(3):142-52. PubMed ID: 12106515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.
    de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Jung-Cook H; Solís-Vivanco R; Graff-Guerrero A; Shungu DC
    Biol Psychiatry; 2018 Mar; 83(6):475-483. PubMed ID: 29132653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression, Cytokine, and Cytokine by Treatment Interactions Modulate Gene Expression in Antipsychotic Naïve First Episode Psychosis.
    Noto C; Ota VK; Santoro ML; Gouvea ES; Silva PN; Spindola LM; Cordeiro Q; Bressan RA; Gadelha A; Brietzke E; Belangero SI; Maes M
    Mol Neurobiol; 2016 Oct; 53(8):5701-9. PubMed ID: 26491028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone.
    Barteček R; Juřica J; Zrůstová J; Kašpárek T; Pindurová E; Žourková A
    Neuro Endocrinol Lett; 2012; 33(2):236-44. PubMed ID: 22592207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone.
    Noto C; Ota VK; Gadelha A; Noto MN; Barbosa DS; Bonifácio KL; Nunes SO; Cordeiro Q; Belangero SI; Bressan RA; Maes M; Brietzke E
    J Psychiatr Res; 2015 Sep; 68():210-6. PubMed ID: 26228421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone in the treatment of psychotic depression.
    Goto M; Yoshimura R; Kakihara S; Shinkai K; Yamada Y; Kaji K; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):701-7. PubMed ID: 16580110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trajectories and antecedents of treatment response over time in early-episode psychosis.
    Levine SZ; Rabinowitz J
    Schizophr Bull; 2010 May; 36(3):624-32. PubMed ID: 18849294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, open study of long-acting injected risperidone versus oral antipsychotics in 88 chronically psychotic patients.
    Girardi P; Serafini G; Pompili M; Innamorati M; Tatarelli R; Baldessarini RJ
    Pharmacopsychiatry; 2010 Mar; 43(2):66-72. PubMed ID: 20099224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.